1.	EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children Phase: Phase IV Type: Treatment Status: Approved-not yet active Age: 6 months to 21 years Sponsor: Other Protocol IDs: SHEBA-06-4013-IK-CTIL, NCT00339118
2.	A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer Phase: Phase IV Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and under Sponsor: NICHD Protocol IDs: PPRU 10762, NCT00491946
3.	Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Under 50 Sponsor: NCI, Other Protocol IDs: CDR0000487560, COG-ARST0531, ARST0531, NCT00354835
4.	Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III Type: Treatment Status: Active Age: Under 21 Sponsor: Other Protocol IDs: CCLG-EPSSG-RMS-2005, EU-20639, EUDRACT-2005-000217-35, UKCCSG-RMS-2005, NCT00379457
5.	Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase II Type: Treatment Status: Active Age: 21 and under Sponsor: Other Protocol IDs: PSCI-2003-232, NCT00084695
6.	Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase II Type: Treatment Status: Active Age: Under 18 Sponsor: Other Protocol IDs: JRSG-UHA-PED03-02, NCT00245089
7.	Radiation Therapy to Treat Musculoskeletal Tumors Phase: Phase II Type: Treatment Status: Active Age: 25 and under Sponsor: Other Protocol IDs: RTSARC, NCT00186992
8.	Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase II Type: Treatment Status: Active Age: Under 18 Sponsor: Other Protocol IDs: JRSG-UHA-PED03-01, NCT00245141
9.	A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma. Phase: Phase II Type: Treatment Status: Active Age: 2 to 17 Sponsor: Pharmaceutical / Industry Protocol IDs: BO20924, 2007-005017-19, NCT00643565
10.	PK/PD of XM22 in Children With Ewing Family of Tumors or Rhabdomyosarcoma Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 2 to 17 Sponsor: Pharmaceutical / Industry Protocol IDs: XM22-07, 2011-004742-18, NCT01585649
11.	Dendritic Cell Vaccine With or Without Gemcitabine Pre-Treatment for Adults and Children With Sarcoma Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 1 to 100 Sponsor: Other Protocol IDs: EPROST-20110462, NCT01803152
12.	Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Under 50 Sponsor: NCI Protocol IDs: NCI-2011-02005, ARST08P1, CDR0000663937, COG-ARST08P1, U10CA098543, NCT01055314
13.	Navigation Surgery for Bone and Soft Tissue Tumor Phase: No phase specified Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: 2008-08-058, NCT01179698
14.	Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases Phase: No phase specified Type: Treatment Status: Active Age: 1 to 29 Sponsor: NCI, Other Protocol IDs: Lung IMRT, NCT01586104